Medical imaging and radiology
Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryAvicenna.AI CINA-ASPECTS medical AI product profile
FDA-cleared computer-aided diagnosis software from Avicenna.AI that calculates ASPECTS from non-contrast head CT and supports clinician assessment of acute ischemic stroke severity.
Medical imaging and radiology
Best fit
Stroke programs that need standardized ASPECTS support, region-level visualization, and radiologist or stroke-physician review within an acute stroke pathway.
- Primary use case
- AI-assisted ASPECTS scoring and heat-map support on non-contrast head CT for suspected acute ischemic stroke assessment
- Audience
- Stroke centers, emergency departments, radiologists, stroke physicians, neuroradiology teams, and health systems evaluating acute ischemic stroke CT workflows
- Risk level
- High
- Pricing signal
- Enterprise radiology and stroke-network pricing; verify current CINA-ASPECTS module, geography, integration, and support terms.
- Official sources
- 6 official sources
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Avicenna.AI CINA-ASPECTS as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Match CINA-ASPECTS to FDA 510(k) K233342, local CE or other market status, exact intended use, software version, age range, scanner manufacturer, and acute-stroke context before using outputs in care decisions. |
|---|---|
| Privacy | Review DICOM routing, identifiers, cloud or on-premise processing, user access, audit logs, retention, support access, incident response, and customer data-processing terms; the public privacy policy mainly covers website interactions and points buyers to compliance documents. |
| Evidence | Evaluate performance on local non-contrast head CT studies against neuroradiologist or stroke-team ASPECTS assessment, including artifacts, scanner mix, early ischemic changes, excluded pathologies, and treatment-decision impact. |
| Workflow | Best governed as clinician-reviewed ASPECTS decision support inside an acute stroke protocol, with explicit ownership for reviewing heat maps, resolving AI-clinician disagreement, documenting decisions, and monitoring drift. |
Where Avicenna.AI CINA-ASPECTS fits
Avicenna.AI describes CINA-ASPECTS as a neurovascular imaging tool that analyzes non-enhanced head CT to calculate ASPECTS, provide heat maps, and support stroke severity assessment; FDA materials list 510(k) K233342 for CINA-ASPECTS and state it is not intended for primary CT interpretation, with validation and use limits around known MCA or ICA occlusion, adult patients over 21, specific scanner manufacturers, and acute brain ischemia within 12 hours from last known well.
Not for: Primary CT interpretation, patients outside the cleared indication, unsupported scanner or pathology contexts, or bypassing neurologist and radiologist review for thrombectomy or thrombolysis decisions.
What to verify before using Avicenna.AI CINA-ASPECTS
- Whether CINA-ASPECTS clearance, software version, age limits, scanner manufacturers, and geography match the planned stroke workflow.
- How non-contrast CT images route from PACS/RIS into CINA-ASPECTS and how ASPECTS scores, heat maps, infarcted regions, and summary charts appear to clinicians.
- Clinical governance for cases with motion, streak artifact, hemorrhagic transformation, hematoma, tumors, abscesses, traumatic injury, or other excluded pathology.
- Local ASPECTS agreement, false positives, false negatives, inter-reader variability, treatment-activation timing, audit logs, downtime handling, and post-deployment monitoring.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- avicenna.ai / solutions / head
- avicenna.ai / fda-clearances-aspects-and-ipe
- www.accessdata.fda.gov / scripts / cdrh
- www.accessdata.fda.gov / cdrh_docs / pdf23
- avicenna.ai / resources / clinical-publications
- avicenna.ai / privacy-policy
Related medical AI products
Medical imaging and radiology
Viz.ai
AI-powered care coordination platform with imaging-driven alerts across therapeutic areas.
Medical imaging and radiology
Ferrum Health
Clinical AI governance and deployment platform for health systems adopting multiple imaging or clinical AI models.
Medical imaging and radiology
Blackford Platform
Enterprise medical imaging AI platform for evaluating, deploying, routing, and monitoring multiple radiology AI applications.